Connection

Sheldon Litwin to Luciferases

Back to Details
This is a "connection" page, showing publications Sheldon Litwin has written about Luciferases.
Sheldon Litwin
Connection Strength
0.049
Luciferases
  1. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet. 2022 03 19; 399(10330):1130-1140.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.